Table 22:
Characteristics of Participants Within Included Studies
| Author, Year | N | Male, n (%) | Age, Years | Ethnicity, n (%) | STS Score (SD), % | NYHA Class, n (%) | Coronary Artery Disease, n (%) | LVEF, % |
|---|---|---|---|---|---|---|---|---|
| Amonn et al, 201369 | 144 (51 TAVI, 93 SAVR) |
TAVI: 26 (51) SAVR: 39 (42) P = .4 |
TAVI: mean 79.7 (SD 9.2) SAVR: mean 81.1 (SD 5.3) P = 1.0 |
NR | TAVI: 6.7 (3.8) SAVR: 4.4 (2.6) P < .001 |
TAVI Class I: 1 (2) Class II: 16 (31) Class III: 28 (55) Class IV: 6 (12) SAVR Class I: 6 (6) Class II: 44 (47) Class III: 36 (39) Class IV: 7 (8) P = .001 |
TAVI: 38 (75) SAVR: 53 (57) P = .047 |
TAVI: mean 49.6 (SD 17.2) SAVR: mean 58.1 (SD 10.3) P = .006 |
| Dharmarajan et al, 201770 | 407 (212 TAVI, 124 SAVR, 71 medical therapy) |
TAVI: 122 (58) SAVR: 81 (65) P = .06 |
TAVI: mean 80.7 (SD 8.6) SAVR: mean 73.2 (SD 9.5) P < .001 |
White TAVI: 205 (97) SAVR: 119 (96) P = .39 |
TAVI: 8.7 (4.5) SAVR: 3.4 (2.4) P < .001 |
TAVI Class III: 106 (50) Class IV: 64 (30) SAVR Class III: 39 (124) Class IV: 22 (18) Class III: P = .003 Class IV: P = .003 |
NR | TAVI: mean 53.9 (SD 12.5) SAVR: mean 56.2 (SD 10.7) P = .20 |
| Marsh et al, 201971 | 93 TAVI | 40 (43) | 19–39: 4 (4%) 40–59: 20 (22%) |
White 87 (94) |
NR | Class I: 53 (57) Class II: 25 (27) |
NR | NR |
| 60–74: 39 (42%) 75–89: 27 (29%) ≥ 90: 3 (3%) |
Class III: 15 (16) Class IV: 0 (0) |
|||||||
| Rosseel et al, 201972 | 429 (164 TAVI, 265 SAVR) |
TAVI: 87 (53) SAVR: 193 (73) P < .001 |
TAVI: Mean 80 (SD 8) SAVR: Mean 70 (SD 10) P < .001 |
NR | TAVI: 3.8 (2.4) SAVR: 3.1 (2.9) P < .001 |
NR | NR | TAVI: mean 48 (SD 13) SAVR: mean 50 (SD 12)P = .905 |
| van Mourik et al, 201873 | 809 TAVI (741 complete follow-up) | 326/741 (44) | Median: 81.9 (IQR 77.3–85.3) | NR | 5.49 (4.73) | Class I: 30/809 (4) Class II: 216/809 (27) Class III: 483/809 (60) Class IV: 80/809 (10) |
NR | Normal: 483/808 (60) Mildly impaired: 157/808 (19)Moderately to severely impaired: 168/808 (21) |
| Wong et al, 201874 | 77 TAVI | 31 (40) | Mean 81.6 (range 61–96) | NR | NR | NR | NR | NR |
Abbreviations: IQR, interquartile range; LVEF, left ventricular ejection fraction; N, number; NR, not reported; NYHA, New York Heart Association; SAVR, surgical aortic valve replacement; SD, standard deviation; STS, Society for Thoracic Surgeons; TAVI, transcatheter aortic valve implantation.